Loading
Latest filing published 11 Oct 2023 for Zynerba Pharmaceuticals, Inc.. Read the official filing
No signal scores available.
All filings by Kenneth T. Jones on record concern Zynerba Pharmaceuticals, Inc. Over a trading history stretching from 12 September 2023 to 10 October 2023, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 11 October 2023, the filings show a transaction in Zynerba Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations